Eben Moglen on Bilski, software patents, and big pharma

Posted by Scott_Ruecker on Aug 7, 2010 2:30 PM EDT
The Prior Art; By Joe Mullin 		Mail this story
Print this story

This interview is part of a series following the Supreme Court's Bilski decision, which left the laws on what you can get a patent on largely as they are, after a four-justice minority failed to ban "business method" patents. Columbia Law School professor Eben Moglen heads the Software Freedom Law Center (SFLC) and wrote the group's amicus brief in Kappos v. Bilski.

Full Story

  Nav
» Read more about: Story Type: Interview; Groups: Community, GNU

« Return to the newswire homepage

This topic does not have any threads posted yet!

You cannot post until you login.